IndyCar Driver Makes Pit Stop at UC Cancer Institute
Just days before the 98th running of the Indianapolis 500, IndyCar driver Pippa Mann visited with researchers and clinicians at University of Cincinnati Cancer Institute.
Mann, who drives a pink Susan G. Komen Verizon IndyCar series car, partnered with the Susan G. Komen Foundation for a visit to the lab of Xiaoting Zhang, PhD, associate professor in the UC Department of Cancer Biology. The visit, held Tuesday, May 20, was part of the Indianapolis 500's annual media day, when each of the 33 drivers travel across the country to make appearances and meet with journalists.
Zhang is a Komen-supported researcher with the Cincinnati Cancer Center and UC Cancer Institute. He uses nanoparticles to study why certain cancers become resistant to the drug tamoxifen.
Following a tour of Zhang's lab in the Vontz Center for Molecular Studies, Mann visited clinicans at the UC Health Barrett Center. Elyse Lower, MD, director of the UC Cancer Institute's Comprehensive Breast Cancer Center and professor in the hematology oncology division at UC, led Mann on a tour through areas newly renovated through the Rooms that Rock for Chemo project.
Mann took to social media during her trip to Cincinnati and from her Twitter account ( @PippaMann), posted to her nearly 18,000 followers: "Amazing tour with @SusanGKomen co-sponsored researcher Dr. Zhang at @uofcincy. Massively important work. #breastcancer #500MediaDay."
Xiaoting Zhang, PhD (left), with IndyCar driver Pippa Mann.
Xiaoting Zhang, PhD (left), with IndyCar driver Pippa Mann and Elyse Lower, MD (right).
Tags
Related Stories
Driven by curiosity, guided by care
May 14, 2026
Max Wilson, a University of Cincinnati College of Allied Health Sciences health sciences major on the pre-physician assistant track, found his path expanding beyond the classroom and into hands-on research focused on human performance and patient care.
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.